Jack Anders
Insider (Form 4 reporting owner): Chief Financial Officer CIK 1800668Name as filed: Anders JackIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 6 Oct 2020, sold $17.5M in 33 sales (21 under a 10b5-1 plan set in advance) of Revolution Medicines.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| Revolution Medicines RVMD | Chief Financial Officer | 6 Oct 2020 | 11 Nov 2026 | – | 33$17.5M |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After sales | +6.5 pts26 trades, 62% above the sector | +11.5 pts25 trades, 64% above the sector | +15.8 pts22 trades, 77% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2026 | – | – | 6 | $12.6M | -$12.6M |
| 2025 | – | – | 7 | $1.9M | -$1.9M |
| 2024 | – | – | 6 | $1.2M | -$1.2M |
| 2023 | – | – | 5 | $837K | -$837K |
| 2022 | – | – | 4 | $34K | -$34K |
| 2021 | – | – | 3 | $15K | -$15K |
| 2020 | – | – | 2 | $840K | -$840K |
Every trade
33, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 11 Nov 2026 | Revolution Medicines RVMD | Sellafter exercising options | 35,750 | $188.10 | $6.7M | 10b5-1 plan | Form 4filed 13 Nov 2026 |
| 16 Sep 2026 | Revolution Medicines RVMD | Sell | 4,053 | $199.24 | $808K | 10b5-1 plan | Form 4filed 18 Sep 2026 |
| 24 Jun 2026 | Revolution Medicines RVMD | Sellafter exercising options | 20,000 | $168.33 | $3.4M | 10b5-1 plan | Form 4filed 26 Jun 2026 |
| 16 Jun 2026 | Revolution Medicines RVMD | Sell | 2,722 | $156.12 | $425K | 10b5-1 plan | Form 4filed 18 Jun 2026 |
| 17 Mar 2026 | Revolution Medicines RVMD | Sell | 2,753 | $99.48 | $274K | 10b5-1 plan | Form 4filed 19 Mar 2026 |
| 7 Jan 2026 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $98.00 | $980K | 10b5-1 plan | Form 4filed 9 Jan 2026 |
| 16 Dec 2025 | Revolution Medicines RVMD | Sell | 3,104 | $77.09 | $239K | 10b5-1 plan | Form 4filed 18 Dec 2025 |
| 25 Nov 2025 | Revolution Medicines RVMD | Sellafter exercising options | 5,418 | $74.00 | $401K | 10b5-1 plan | Form 4filed 26 Nov 2025 |
| 11 Nov 2025 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $64.00 | $640K | 10b5-1 plan | Form 4filed 13 Nov 2025 |
| 16 Sep 2025 | Revolution Medicines RVMD | Sell | 2,320 | $45.82 | $106K | 10b5-1 plan | Form 4filed 18 Sep 2025 |
| 2 Sep 2025 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $40.10 | $401K | 10b5-1 plan | Form 4filed 4 Sep 2025 |
| 16 Jun 2025 | Revolution Medicines RVMD | Sell | 2,170 | $39.83 | $86K | 10b5-1 plan | Form 4filed 18 Jun 2025 |
| 17 Mar 2025 | Revolution Medicines RVMD | Sell | 1,864 | $39.04 | $73K | 10b5-1 plan | Form 4filed 19 Mar 2025 |
| 16 Dec 2024 | Revolution Medicines RVMD | Sell | 2,635 | $45.40 | $120K | 10b5-1 plan | Form 4filed 18 Dec 2024 |
| 11 Oct 2024 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $50.30 | $503K | 10b5-1 plan | Form 4filed 15 Oct 2024 |
| 16 Sep 2024 | Revolution Medicines RVMD | Sell | 2,244 | $44.19 | $99K | 10b5-1 plan | Form 4filed 18 Sep 2024 |
| 17 Jun 2024 | Revolution Medicines RVMD | Sell | 1,893 | $37.39 | $71K | 10b5-1 plan | Form 4filed 20 Jun 2024 |
| 3 May 2024 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $40.03 | $400K | 10b5-1 plan | Form 4filed 3 May 2024 |
| 18 Mar 2024 | Revolution Medicines RVMD | Sell | 1,261 | $31.58 | $40K | 10b5-1 plan | Form 4filed 20 Mar 2024 |
| 18 Dec 2023 | Revolution Medicines RVMD | Sell | 1,775 | $25.90 | $46K | 10b5-1 plan | Form 4filed 20 Dec 2023 |
| 18 Sep 2023 | Revolution Medicines RVMD | Sell | 1,427 | $31.31 | $45K | No | Form 4filed 20 Sep 2023 |
| 1 Sep 2023 | Revolution Medicines RVMD | Sellafter exercising options | 20,000 | $35.05 | $701K | 10b5-1 plan | Form 4filed 6 Sep 2023 |
| 20 Jun 2023 | Revolution Medicines RVMD | Sell | 1,249 | $24.89 | $31K | No | Form 4filed 22 Jun 2023 |
| 17 Mar 2023 | Revolution Medicines RVMD | Sell | 665 | $21.78 | $14K | No | Form 4filed 21 Mar 2023 |
| 19 Dec 2022 | Revolution Medicines RVMD | Sell | 658 | $22.94 | $15K | Not stated | Form 4filed 21 Dec 2022 |
| 19 Sep 2022 | Revolution Medicines RVMD | Sell | 449 | $19.04 | $9K | Not stated | Form 4filed 21 Sep 2022 |
| 17 Jun 2022 | Revolution Medicines RVMD | Sell | 406 | $17.75 | $7K | Not stated | Form 4filed 22 Jun 2022 |
| 17 Mar 2022 | Revolution Medicines RVMD | Sell | 159 | $18.62 | $3K | Not stated | Form 4filed 21 Mar 2022 |
| 17 Dec 2021 | Revolution Medicines RVMD | Sell | 170 | $24.41 | $4K | Not stated | Form 4filed 21 Dec 2021 |
| 17 Sep 2021 | Revolution Medicines RVMD | Sell | 166 | $30.02 | $5K | Not stated | Form 4filed 21 Sep 2021 |
| 17 Jun 2021 | Revolution Medicines RVMD | Sell | 160 | $34.12 | $5K | Not stated | Form 4filed 22 Jun 2021 |
| 13 Oct 2020 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $44.00 | $440K | Not stated | Form 4filed 15 Oct 2020 |
| 6 Oct 2020 | Revolution Medicines RVMD | Sellafter exercising options | 10,000 | $40.00 | $400K | Not stated | Form 4filed 8 Oct 2020 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.